# Effects of Psilocybin in Obsessive Compulsive Disorder

> **NCT05546658** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 35 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT05546658
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-28
- **Primary completion:** 2026-09-12
- **Final completion:** 2027-09-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05546658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05546658, "Effects of Psilocybin in Obsessive Compulsive Disorder". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05546658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*